Shared Decision Making: Prostate Cancer Screening
1 other identifier
interventional
641
1 country
1
Brief Summary
Interventions to Improve Shared Decision-Making: Prostate Cancer Screening is a prospective study of educational interventions to improve the interaction of physicians and their patients about prostate cancer screening. Educational material is provided in primary care practices using either standard paper information or a novel web-based interactive curriculum that explores the risks and benefits of screening measures for prostate cancer for older men. The impact of the intervention on shared decision-making with both actual and standardized patients will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable prostate-cancer
Started Nov 2005
Typical duration for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedStudy Start
First participant enrolled
November 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedOctober 8, 2024
October 1, 2024
4.3 years
September 14, 2005
October 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intervention groups (physician education only, both physician and patient education) vs. control group comparison of physician shared decision-making (SDM) behaviors (self-reported SDM and SDM reported by actual and standardized patients)
study period
Secondary Outcomes (3)
1.Pre- and post-study changes in physician knowledge and attitudes about PSA
study period
2.Pre- and post-study changes in physicians' PSA ordering behavior for their patients age 50-75 years
study period
3.Patients post-visit knowledge and attitudes about PSA
study period
Study Arms (3)
Control group
NO INTERVENTIONstandard informational brochures
Web curriculum for physicians only
EXPERIMENTALBoth intervention arms will use a novel web-based interactive curriculum that provides education about prostate cancer screening, including potential benefits and harms, fundamentals of effective patient counsel, and shared decision-making. In one of the intervention arms, the physicians saw the web-based interactive curriculum and the patient received the brochure.
Web curriculum for physicians and patients
EXPERIMENTALIn the other intervention arm, the physicians saw the web-based curriculum and the patient received interactive curriculum covering content similar to that contained in the web-based interactive curriculum for physicians.
Interventions
Interventions to Improve Shared Decision-Making: Prostate Cancer Screening is a prospective study of educational interventions to improve shared decision-making of physicians and their patients about prostate cancer screening. Physicians will be randomized by practice site to receive standard informational brochures (control group) or a novel web-based interactive curriculum that provides education about prostate cancer screening, including potential benefits and harms, fundamentals of effective patient counsel, and shared decision-making. In addition, patients at intervention sites will be randomized to receive either the brochure or a patient-oriented interactive curriculum covering content similar to that contained in the physician tool. Physicians in all groups will also see one unannounced standardized patient (SP) trained to portray a patient interested in discussing PSA.
Eligibility Criteria
You may qualify if:
- Physicians in primary care practice settings with male patients age 50-75
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lisa Richarsonlead
Study Sites (1)
University of California Davis, Center for Health Services Research
Sacramento, California, 95817, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael S Wilkes, MD PhD
University of California, Davis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Director for Science
Study Record Dates
First Submitted
September 14, 2005
First Posted
September 21, 2005
Study Start
November 1, 2005
Primary Completion
March 1, 2010
Study Completion
February 1, 2011
Last Updated
October 8, 2024
Record last verified: 2024-10